High-Grade Cervical Intraepithelial Neoplasia: Impact of Colposcopic Lesion Area on Systemic Immune Responses
Authors:
- Priscila Thaís Silva MantoaniPMPriscila Thaís Silva Mantoani
- Douglas Côbo MicheliDMDouglas Côbo Micheli
- Millena Prata JammalMJMillena Prata Jammal
- Julia Hailer VieiraJVJulia Hailer Vieira
- Márcia Antoniazi MichelinMMMárcia Antoniazi Michelin
- Caroline Gabriela Xavier FerreiraCFCaroline Gabriela Xavier Ferreira
- Henrique Nascimento SilvaHSHenrique Nascimento Silva
- Eddie Fernando Candido MurtaEMEddie Fernando Candido Murta
- Rosekeila Simões NomeliniRNRosekeila Simões Nomelini
Open Access
- 1 February 2025
- journal article
- research article
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 345-353
Abstract
Background: The progression of high-grade cervical intraepithelial neoplasia (CIN) and cervical cancer is accompanied by a reduction in the immune response. The objectives of the study were to determine whether colposcopic lesion area is associated with serum levels of cytokines IL (interleukin) − 1, IL-6, IL-8, IL-10, IL-12 and TNF-α in precursor lesions of cervical cancer. Methods: The study population comprised patients with high-grade squamous intraepithelial lesion who had undergone colposcopy, cervical biopsy, and measurements of serum cytokines by ELISA (Enzyme-Linked Immunosorbent Assay). Genotyping for HPV (human papillomavirus) 16, 18, 45 and 52 was performed by PCR (Polymerase Chain Reaction). ROC (Receiver Operating Characteristic) curves were calculated to determine whether there existed a cut-off value for serum cytokines in patients with colposcopic lesion area smaller vs larger than 1 cm2. For cytokines with significant results, these cut-off values were used to perform the multivariable analysis. Results: There were 71 patients with CIN 2/3. ROC curves were calculated to verify a cut-off value for serum cytokine levels that could be used to distinguish between lesion areas < 1 cm2 vs ≥ 1 cm2. Values with statistical significance were IL-1 > 13.3 pg/mL and IL-12 ≤ 349.6 pg/mL. In the multivariable analysis, the independent variables associated with colposcopic lesion area greater than 1cm2 were IL-1> 13.3 pg/mL and IL-12 ≤ 349.6 pg/mL [OR (95% CI) = 10.10 (1.50– 67.96); OR (95% CI)=10.70 (1.17– 97.45), respectively]. Conclusion: Although CIN 2/3 is a local uterine cervix lesion, there is a systemic immunological response. Our results are unprecedented and could be the target of new important studies in public health and cervical cancer prevention.Keywords
This publication has 32 references indexed in Scilit:
- The multifaceted role of IL-12 in cancerAdvances in Cancer Biology - Metastasis, 2022
- Management of cervical premalignant lesionsCurrent Problems in Cancer, 2018
- Immune evasion mechanisms of human papillomavirus: An updateInternational Journal of Cancer, 2017
- Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasiaInternational Journal of Clinical Oncology, 2014
- Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasiaHuman Immunology, 2012
- Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate DeterminationImmunity, 2008
- Cancer-related inflammationNature, 2008
- The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactionsCancer and Metastasis Reviews, 2006
- Cervicovaginal coinfections with human papillomavirus and chlamydia trachomatisDiagnostic Microbiology and Infectious Disease, 2002
- Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyThe Lancet, 1999